Floatz logo

Therapeutic Asset Ratings

423 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Amg 355
Cancer
AmgenP1C (36)
Amt-562
Cancer
Multitude Therapeutics (Australia) Pty LtdP1C (36)
ap505
Cancer
AP Biosciences Inc.P1C (36)
Askg315
Cancer
AskGene Pharma, Inc.P1C (36)
asp1002
Cancer
Astellas Pharma Global Development, Inc.P1C (36)
asp2074
Cancer
Astellas Pharma Global Development, Inc.P1C (36)
at1019
Cancer
The Affiliated Hospital of Xuzhou Medical UniversityP1C (36)
Atg-018
Cancer
Antengene Discovery LimitedP1C (36)
Atg-031
Cancer
Antengene Biologics LimitedP1C (36)
Atv-1601
Cancer
Atavistik Bio, IncP1C (36)
Atx-295
Cancer
Accent TherapeuticsP1C (36)
Atx-559
Cancer
Accent TherapeuticsP1C (36)
bat8007 for
Cancer
Bio-Thera SolutionsP1C (36)
bat8008 for
Cancer
Bio-Thera SolutionsP1C (36)
bay2965501
Cancer
BayerP1C (36)
Bevacizumab-Awwb
Cancer
AmgenP1C (36)
Bgb-30813
Cancer
BeiGeneP1C (36)
Bg-C477
Cancer
BeOne MedicinesP1C (36)
Bgm-2121
Cancer
BioGate Precision Medicine Corp.P1C (36)
bm201
Cancer
InnoBM Pharmaceuticals Co., Ltd.P1C (36)
BMS-986484
Cancer
Bristol-Myers SquibbP1C (36)
BMS-986504
Cancer
Bristol-Myers SquibbP1C (36)
bpt567
Cancer
Bright Peak Therapeutics IncP1C (36)
Btm-3566
Cancer
Bantam PharmaceuticalsP1C (36)
cd-001
Cancer
CD (Suzhou) Biopharma Co., Ltd.P1C (36)
Showing 226 to 250 of 423 assets
PreviousPage 10 of 17Next